Victor Fabano
Chief Operating Officer bij OSPY MEDI CDI
Actieve functies van Victor Fabano
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OSPY MEDI CDI | Chief Operating Officer | 01-06-2012 | - |
| Chief Tech/Sci/R&D Officer | 01-08-2018 | - |
Loopbaan van Victor Fabano
Eerdere bekende functies van Victor Fabano
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Anulex Technologies, Inc.
 Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Chief Operating Officer | 02-02-2010 | 01-01-2012 |
Opleiding van Victor Fabano
| University of North Dakota | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Anulex Technologies, Inc.
Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Health Technology |
Osprey Medical, Inc.
 Osprey Medical, Inc. Medical SpecialtiesHealth Technology Osprey Medical, Inc. engages in the development to prevent harmful effect of x-ray dye used during angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN. | Health Technology |
- Beurs
- Insiders
- Victor Fabano
- Ervaring
